296 related articles for article (PubMed ID: 30451838)
1. Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function.
Wang F; Meng M; Mo B; Yang Y; Ji Y; Huang P; Lai W; Pan X; You T; Luo H; Guan X; Deng Y; Yuan S; Chu J; Namaka M; Hughes T; Ye L; Yu J; Li X; Deng Y
Nat Commun; 2018 Nov; 9(1):4874. PubMed ID: 30451838
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 and mTORC2 differentially promote natural killer cell development.
Yang C; Tsaih SW; Lemke A; Flister MJ; Thakar MS; Malarkannan S
Elife; 2018 May; 7():. PubMed ID: 29809146
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature.
Yang C; Siebert JR; Burns R; Zheng Y; Mei A; Bonacci B; Wang D; Urrutia RA; Riese MJ; Rao S; Carlson KS; Thakar MS; Malarkannan S
Elife; 2020 May; 9():. PubMed ID: 32406817
[TBL] [Abstract][Full Text] [Related]
4. Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells.
Venugopal SV; Caggia S; Gambrell-Sanders D; Khan SA
Prostate; 2020 Apr; 80(5):412-423. PubMed ID: 31995655
[TBL] [Abstract][Full Text] [Related]
5. Roles of mTORC1 and mTORC2 in controlling γδ T1 and γδ T17 differentiation and function.
Yang Q; Liu X; Liu Q; Guan Z; Luo J; Cao G; Cai R; Li Z; Xu Y; Wu Z; Xu M; Zhang S; Zhang F; Yang H; Lin X; Yang M; Wu Y; Gao Y; Flavell R; Hao J; Yin Z
Cell Death Differ; 2020 Jul; 27(7):2248-2262. PubMed ID: 32001780
[TBL] [Abstract][Full Text] [Related]
6. mTORC1 and mTORC2 coordinate early NK cell development by differentially inducing E4BP4 and T-bet.
Li D; Wang Y; Yang M; Dong Z
Cell Death Differ; 2021 Jun; 28(6):1900-1909. PubMed ID: 33462410
[TBL] [Abstract][Full Text] [Related]
7. NK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activation.
Yang M; Chen S; Du J; He J; Wang Y; Li Z; Liu G; Peng W; Zeng X; Li D; Xu P; Guo W; Chang Z; Wang S; Tian Z; Dong Z
Nat Commun; 2016 Sep; 7():12730. PubMed ID: 27601261
[TBL] [Abstract][Full Text] [Related]
8. mTORC2 acts as a gatekeeper for mTORC1 deficiency-mediated impairments in ILC3 development.
Deng YF; Wu ST; Peng HY; Tian L; Li YN; Yang Y; Meng M; Huang LL; Xiong PW; Li SY; Yang QL; Wang LL; Li XY; Li LP; Lu XL; Li XH; Wei YL; Xiao ZH; Yu JH; Deng YC
Acta Pharmacol Sin; 2023 Nov; 44(11):2243-2252. PubMed ID: 37407703
[TBL] [Abstract][Full Text] [Related]
9. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
Zhang X; Wang X; Xu T; Zhong S; Shen Z
Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
[TBL] [Abstract][Full Text] [Related]
10. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Target of Rapamycin Complex 1 Promotes the Expression of Genes Encoding Electron Transport Chain Proteins and Stimulates Oxidative Phosphorylation in Primary Human Trophoblast Cells by Regulating Mitochondrial Biogenesis.
Rosario FJ; Gupta MB; Myatt L; Powell TL; Glenn JP; Cox L; Jansson T
Sci Rep; 2019 Jan; 9(1):246. PubMed ID: 30670706
[TBL] [Abstract][Full Text] [Related]
12. Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination.
Bercury KK; Dai J; Sachs HH; Ahrendsen JT; Wood TL; Macklin WB
J Neurosci; 2014 Mar; 34(13):4466-80. PubMed ID: 24671993
[TBL] [Abstract][Full Text] [Related]
13. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
14. Loss of
Babaev VR; Huang J; Ding L; Zhang Y; May JM; Linton MF
Front Immunol; 2018; 9():215. PubMed ID: 29487597
[TBL] [Abstract][Full Text] [Related]
15. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
[TBL] [Abstract][Full Text] [Related]
16. mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells.
Zheng B; Wang J; Tang L; Shi J; Zhu D
Int J Dev Biol; 2017; 61(1-2):65-72. PubMed ID: 28287249
[TBL] [Abstract][Full Text] [Related]
17. Genetic inactivation of mTORC1 or mTORC2 in neurons reveals distinct functions in glutamatergic synaptic transmission.
McCabe MP; Cullen ER; Barrows CM; Shore AN; Tooke KI; Laprade KA; Stafford JM; Weston MC
Elife; 2020 Mar; 9():. PubMed ID: 32125271
[TBL] [Abstract][Full Text] [Related]
18. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
19. A role for Blimp1 in the transcriptional network controlling natural killer cell maturation.
Kallies A; Carotta S; Huntington ND; Bernard NJ; Tarlinton DM; Smyth MJ; Nutt SL
Blood; 2011 Feb; 117(6):1869-79. PubMed ID: 21131593
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function.
Deng Y; Kerdiles Y; Chu J; Yuan S; Wang Y; Chen X; Mao H; Zhang L; Zhang J; Hughes T; Deng Y; Zhang Q; Wang F; Zou X; Liu CG; Freud AG; Li X; Caligiuri MA; Vivier E; Yu J
Immunity; 2015 Mar; 42(3):457-70. PubMed ID: 25769609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
